Link Jastreboff et al., NEJM 2023 (Phase 2 obesity)
This class of medication has been available for a while, but these drugs really became popular in the past couple years because of their effects on weight management, co-author Serena Jingchuan Guo, MD, PhD, associate professor and AI director at Purdue University College of Pharmacy, told Healio
Beyond those standing concerns, in a press announcement dated March 3, 2026 (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products
Detail How To Use 1
Were here to provide ongoing support to help you stay on track